Literature DB >> 18558581

Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes.

I Rubio1, F Pedreira, I Roca, A Cabaleiro, C Mendoza, O Córdoba, T Cortadellas, D Sabadell, J Xercavins.   

Abstract

OBJECTIVE: The aim of this study is to evaluate if it is necessary to remove all the radioactive sentinel lymph nodes (SLNs) not seen on lymphoscintigraphy in order to accurately stage breast cancer patients.
MATERIAL AND METHODS: From March 1999 to March 2006, SLN biopsy was performed in 461 patients. All patients were only injected with radioisotope. Lymphoscintigraphy was performed in all the patients. The mean number of SLNs removed was 2.1 (range 1-15).
RESULTS: The SLN was positive in 133 patients (28.8%). Lymphoscintigraphy accurately predicted the number of SLNs identified intraoperatively in 243 patients (52.7%). In 175 patients (37.9%) there were more SLNs identified intraoperatively than were seen on lymphos cintigraphy. In 11 (6.2%) of these 175 patients, additional SLNs identified intraoperatively harboured metastasis. Type of injection, need for a second injection, tumour location and age were not identified as statistically significantly associated with additional positive SLNs identified intraoperatively and not seen on lymphoscintigraphy.
CONCLUSIONS: Lymphoscintigraphy does not accurately predict the number of SLNs identified intraoperatively, this number being underestimated. Surgeons should remove all radioactive SLNs to improve the detection of positive SLNs.

Entities:  

Mesh:

Year:  2008        PMID: 18558581     DOI: 10.1007/s12094-008-0210-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  22 in total

1.  Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer.

Authors:  Angela Shoher; Amna Diwan; Bin S Teh; Hsin H Lu; Ron Fisher; Anthony Lucci
Journal:  Curr Surg       Date:  2006 May-Jun

2.  Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer.

Authors:  Lei Wang; Jin-ming Yu; Yong-sheng Wang; Wen-shu Zuo; Yan Gao; Jiang Fan; Ji-yu Li; Xu-dong Hu; Ming-lu Chen; Guo-ren Yang; Zheng-bo Zhou; Yan-song Liu; Yong-qing Li; Yan-bing Liu; Tong Zhao; Peng Chen
Journal:  Ann Surg Oncol       Date:  2007-05-24       Impact factor: 5.344

3.  Subareolar injection of 99mTc facilitates sentinel lymph node identification.

Authors:  Todd M Tuttle; Marybeth Colbert; Robert Christensen; Kevin J Ose; Thomas Jones; Robert Wetherille; Joel Friedman; Karen Swenson; Kelly M McMasters
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

4.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

5.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

6.  Subareolar versus peritumoral injection for location of the sentinel lymph node.

Authors:  V S Klimberg; I T Rubio; R Henry; C Cowan; M Colvert; S Korourian
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

7.  Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.

Authors:  K M McMasters; S L Wong; R C Martin; C Chao; T M Tuttle; R D Noyes; D J Carlson; A L Laidley; T Q McGlothin; P B Ley; C M Brown; R L Glaser; R E Pennington; P S Turk; D Simpson; P B Cerrito; M J Edwards
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

8.  Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.

Authors:  M H Doting; L Jansen; O E Nieweg; D A Piers; A T Tiebosch; H S Koops; E J Rutgers; B B Kroon; J L Peterse; R A Olmos; J de Vries
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

9.  Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.

Authors:  Anees Chagpar; Robert C Martin; Celia Chao; Sandra L Wong; Michael J Edwards; Todd Tuttle; Kelly M McMasters
Journal:  Arch Surg       Date:  2004-06

10.  Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

Authors:  Jean-François Rodier; Michel Velten; Marc Wilt; Pierre Martel; Gwanaël Ferron; Véronique Vaini-Elies; Hervé Mignotte; Alain Brémond; Jean-Marc Classe; François Dravet; Thierry Routiot; Christine Tunon de Lara; Antoine Avril; Gérard Lorimier; Eric Fondrinier; Gilles Houvenaeghel; Sandrine Avigdor
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.